Overview
Addus Q3 net service revenues up 25% yr/yr to $362.3 mln
Adjusted EPS for Q3 beats analyst expectations
Adjusted EBITDA for Q3 beats analyst expectations
Company completed Del Cielo acquisition on Oct 1, expanding Texas operations
Outlook
Company anticipates positive impact from recent Texas rate increase
Addus expects continued growth in hospice care business
Company plans to leverage acquisitions for sustained success
Result Drivers
PERSONAL CARE GROWTH - Personal care segment accounted for 76.1% of revenues, driven by acquisitions and rate increases in key markets
HOSPICE REVENUE INCREASE - Hospice segment saw 19% organic revenue growth due to higher admissions and operational improvements
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Adjusted EPS
Beat
$1.56
$1.53 (10 Analysts)
Q3 Adjusted Net Income
Beat
$28.7 mln
$27.3 mln (11 Analysts)
Q3 Net Income
$22.8 mln
Q3 Adjusted EBITDA
Beat
$45.1 mln
$44.4 mln (11 Analysts)
Q3 Operating Cash Flow
$51.3 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", no "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Addus Homecare Corp is $145.00, about 19.4% above its October 31 closing price of $116.89
The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 17 three months ago
Press Release: ID:nBw7RFHsTa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)